At present, the following major categories of drugs are clinically used for cerebral infarction infusion: the first category is cerebral protective agents, including free radical scavengers, magnesium ions, excitatory amino acid receptor blockers, etc., of which the representative drugs are edaravone and olanzapine; the second category is Chinese medicinal preparations, such as Salvia miltiorrhiza, geranium, Panax ginseng, which improve the symptoms of cerebral infarction by activating blood circulation and removing blood stasis; the third category is drugs to reduce cerebral edema, such as mannitol, mannofructose, diuretics; the fourth category is drugs for complications, and some patients with cerebral infarction with consciousness disorders are prone to respiratory infections in the acute stage, and drugs for anti-infection treatment must be used. The above four categories of infusion drugs are the main ones, but lastly, we should emphasize that cerebral infarction is a very complex pathophysiological process, and the clinical emphasis is on individualized treatment plan, so not every patient can get good recovery and treatment by using the above infusion drugs. In addition to the infusion drugs, there are also some oral drugs combined to develop individualized treatment measures, so that the patient can eventually recover as soon as possible.